IS:ASTRAZEN Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. The company offers products in the areas of cardiovascular, renal, metabolic, oncology, neuroscience, and gastrointestinal, as well as respiratory, inflammation, and autoimmunity diseases; and infection and vaccine products under the Brilinta, Betaloc, Seloken XL, Imdur, Crestor, Forxiga, Onglyza, Kombiglyze XR, Xigduo, Symbicort, Arimidex, Iressa, Zoladex, Casodex, Faslodex, and Tagrisso brands. It also provides clinical trial services on pharmaceutical products. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca PLC.

3,018.55 INR
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  07/30/1998
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   76,632,121,344 INR
Current dividend yield:   0.13%
Sedol:      B170D88

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy